Newly acquired Toronto Blue Jays pitcher Nic Enright will spend first year of contract rehabilitating injury

The Blue Jays are taking a shot at some pitching depth beyond the 2026 season when righty reliever Nic Enright signed a two-year minor-league deal.

However, Enright will spend the 2026 season rehabbing from Tommy John surgery.

A 20th-round pick by Cleveland back in 2019, the righty made his way up the organizational ladder to reach Triple-A with excellent results in 2022.

That seemingly put him on the radar for a call-up to the majors, but was diagnosed with Hodgkin Lymphoma in December of that year.

The diagnosis came shortly after Enright was selected by the Marlins in the Rule 5 draft and severely limited him throughout the 2023 campaign, although he did eventually begin a rehab assignment while undergoing treatment.

He struggled before being returned to the Guardians, but by 2024 was back to posting excellent numbers in the minors.

That earned Enright the opportunity to make his MLB debut this year, and he made the most of the opportunity with a sterling 2.03 ERA and a 23.7% strikeout rate in 31 innings of work.

Enright had the look of a quality bullpen piece when on the mound, but his health derailed things once again when the righty underwent Tommy John surgery in October.

The timing of that injury will cost Enright the entire 2026 season, which led the Guardians to non-tender him last month despite his status as a pre-arbitration player.

That sent Enright into minor league free agency for the first time in his career, and he's now managed to catch on with the reigning AL champions.